What is the main focus of Surajit Sarkar's 2011 review on heat shock proteins?

The review focuses on the role of heat shock proteins (HSPs) in cellular protection and their involvement in various diseases, including cancer and neurodegenerative disorders. It highlights how HSPs assist in protein folding and prevent aggregation under stress conditions.

What are heat shock proteins and why are they important according to the 2011 review?

Heat shock proteins are molecular chaperones that help cells survive stress by refolding damaged proteins and preventing aggregation. The review emphasizes their critical role in maintaining cellular homeostasis and their potential as therapeutic targets.

How does Surajit Sarkar's review relate heat shock proteins to cancer?

The review discusses how HSPs are often overexpressed in cancer cells, promoting tumor survival and resistance to therapy. It suggests that inhibiting specific HSPs could be a strategy for cancer treatment.

What neurodegenerative diseases are linked to heat shock proteins in the 2011 review?

The review connects HSPs to Alzheimer's, Parkinson's, and Huntington's diseases, where protein misfolding and aggregation are key features. It explains that HSPs can mitigate toxicity by refolding or degrading abnormal proteins.

Surajit Sarkar Heat Shock Proteins Review 2011: Key Insights

Heat shock proteins (HSPs) are molecular chaperones that cells produce in response to stress, including high temperatures, toxins, and infection. The 2011 review by Surajit Sarkar, published in a peer-reviewed journal, analyzed how these proteins function in cellular protection and what their dysregulation means for human disease. Sarkar’s work synthesized existing research to highlight the dual role of HSPs as both protective agents and contributors to pathology when their expression goes wrong.

The Core Function of Heat Shock Proteins

Sarkar’s review began by grounding readers in the basic biology of HSPs. These proteins are classified by molecular weight, with major families including HSP27, HSP70, HSP90, and HSP60. Under normal conditions, they assist in the proper folding of nascent polypeptides and the refolding of damaged proteins. When a cell experiences stress, HSP expression increases sharply to prevent protein aggregation and to facilitate repair.

The review emphasized that HSPs actively bind to exposed hydrophobic regions of misfolded proteins, preventing them from clumping together. This chaperone activity is essential for maintaining the proteome. Without HSPs, cells would accumulate toxic aggregates that disrupt normal function and trigger cell death.

HSP70 and HSP90 in Stress Response

Sarkar dedicated significant attention to the HSP70 and HSP90 families. HSP70 works early in the stress response, binding to nascent or damaged proteins and using energy from ATP hydrolysis to drive correct folding. HSP90 is more specialized, helping mature a specific set of client proteins involved in signal transduction and cell cycle regulation.

The review pointed out that HSP90 is particularly important for the stability of oncoproteins that drive cancer growth. This connection makes HSP90 a target for cancer therapy. The review also noted that HSP70 can inhibit apoptosis by interacting with key components of the cell death machinery. This protective effect can be beneficial in normal tissues but harmful when it allows cancer cells to survive.

Heat Shock Proteins in Disease

One central theme of Sarkar’s review was the conflicting roles of HSPs in different diseases. In neurodegenerative disorders such as Alzheimer’s, Parkinson’s, and Huntington’s, protein aggregation is a hallmark. HSPs can help disaggregate these toxic clumps, but Sarkar noted that in many cases, the chaperone capacity of HSPs is overwhelmed and the aggregates persist.

In cancer, many tumors overexpress HSP70 and HSP90 to support rapid cell division and resist chemotherapy-induced stress. Sarkar cited evidence that high HSP levels correlate with poor prognosis in several cancer types. The review argued that targeting HSPs with inhibitors could sensitize cancer cells to treatment. For example, the HSP90 inhibitor geldanamycin and its derivatives showed promise in preclinical studies, though toxicity remains a challenge.

Sarkar also discussed the role of HSPs in autoimmune diseases. Because HSPs are highly conserved across species, bacterial HSPs can trigger an immune response that cross-reacts with human HSPs. This molecular mimicry may contribute to conditions like rheumatoid arthritis and type 1 diabetes. At the same time, some HSPs have anti-inflammatory properties, suggesting a complex regulatory network.

Therapeutic Implications

The review outlined several therapeutic strategies being explored at the time. One approach was to use small-molecule inhibitors to block HSP90 in cancer cells, destabilizing the oncoproteins that depend on it. Another was to induce HSP expression as a protective measure in ischemic injury or neurodegenerative disease. For instance, pharmacological inducers like geranylgeranylacetone were shown to increase HSP70 levels and reduce tissue damage in animal models of stroke.

Sarkar also highlighted the potential of HSP-based vaccines. Tumor cells often present HSP-peptide complexes on their surface, and these complexes can be isolated and used to stimulate an anti-tumor immune response. Clinical trials using autologous HSP-peptide complexes for cancer immunotherapy were underway at the time, with some positive results in melanoma and renal cell carcinoma.

The review acknowledged significant hurdles. HSP inhibitors can cause off-target effects because HSPs are essential in normal cells. Inducing HSPs in neurodegenerative disease is tricky because timing and dosage must be precise to avoid promoting cancer. Sarkar called for more research into isoform-specific inhibitors and delivery systems that target diseased tissues.

Key Takeaways

Sarkar’s 2011 review provided a comprehensive overview of heat shock protein biology, focusing on HSP70 and HSP90 as central players in stress response and disease.
HSPs have a dual role: they protect cells from stress and help maintain protein homeostasis, but their overexpression can promote cancer and contribute to autoimmune pathology.
Therapeutic strategies discussed include HSP90 inhibitors for cancer, HSP inducers for neurodegeneration, and HSP-based vaccines for immunotherapy.
The review emphasized that successful clinical translation requires better specificity and delivery methods to avoid harming healthy tissues.